Cooperative Agreement U48DP006843
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$800K
Funding Federal Agency
National Center for Immunization and Respiratory Diseases
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.323
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
The City of New York, through its Department of Health and Mental Hygiene (Health Dept), was awarded a $5,540,511 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). This five-year grant, effective from August 1, 2024 to July 31, 2029, supports the Health Dept's efforts to enhance public health infrastructure for detecting, responding to, preventing, and controlling...
The Centers for Disease Control and Prevention (CDC) awarded the Palau Ministry of Health and Human Services a Cooperative Agreement under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The $220,886 award, effective August 1, 2024 through July 31, 2029, will support the Ministry's efforts to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases in Palau. Key activities funded through...
The federal Cooperative Agreement award for $4,252,680.00, titled "2024 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)," was awarded by the Centers for Disease Control and Prevention (CDC) on August 1, 2024. The award is part of the CDC's Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program, which aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling...
The South Carolina Department of Public Health (SCDPH) was awarded a $3,123,525 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award, effective August 1, 2024 through July 31, 2029, aims to enhance SCDPH's capacity to detect, respond, prevent, and control known and emerging infectious diseases. Key strategies include: 1) building a skilled, diverse public...
The Centers for Disease Control and Prevention (CDC) awarded a 5-year, $367,944 Cooperative Agreement titled "Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC)" (CFDA 93.185) to the Indiana Department of Health. This funding supports strengthening epidemiologic and laboratory capacity, enhancing information systems, and improving collaboration among public health departments to detect, respond to, and control emerging infectious...
The State of Alaska Department of Health has been awarded a $650,999 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) program (CFDA 93.283). The grant funding will be used by the Alaska Division of Public Health to strengthen and enhance key aspects of public health infectious disease surveillance, including ensuring competent disease investigation and...
This Cooperative Agreement award, valued at $2,618,602.00, was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award supports North Carolina's efforts to enhance epidemiological surveillance, laboratory testing capabilities, and interdisciplinary collaboration for detecting, responding to, preventing, and controlling infectious disease threats. Key activities include...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $2,688,933 cooperative agreement under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) to The Task Force for Global Health, Inc., a non-profit organization based in Decatur, Georgia. This 5-year award, effective August 1, 2024 through July 31, 2029, supports the organization's work in global health research, disease surveillance, and health systems strengthening. The Task Force...
This $1,662,126 Cooperative Agreement was awarded by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award is intended to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases in Kentucky. Key products and services to be delivered include: Strengthening epidemiological surveillance, laboratory testing capabilities, and health...
The federal Cooperative Agreement award NU51CK000343, funded by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), provides $1,830,778 to the Massachusetts Department of Public Health (MDPH) to enhance the state's public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. The ELC program supports a range of activities including epidemiological...